Cyclin B1 promoter activity and functional CDK1 complex formation in G1 phase of human breast cancer cells

被引:28
作者
Barrett, KLB [1 ]
Demiranda, D [1 ]
Katula, KS [1 ]
机构
[1] Univ N Carolina, Dept Biol, Greensboro, NC 27402 USA
关键词
BT-549; cell cycle; cyclin B1; cyclin-dependent kinase; MCF-10F; MDA-MB-157; promoter activity; T-47D;
D O I
10.1006/cbir.2001.0817
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Overexpression of cyclin B has been detected in various human breast cancer cell lines, breast tumor tissues, and immortalized but nontransformed breast cells. The cause of this overexpression has not been thoroughly investigated, nor is it known if cyclin B protein forms a functional complex with its partner, cdk1, at inappropriate cell cycle periods. In this study we examined the pattern of cyclin B1 promoter activity in three breast cancer cell lines, BT-549, MDA-MB-157, T-47D, and the immortalized breast cell line MCF-10F. Using cells stably transfected with a cyclin B1 promoter-luciferase reporter, luciferase activity was measured throughout the cell cycle in lovastatin synchronized cells and in G1 and S/G2 phases of asynchronized cells by flow cytometry. Results demonstrate that the cyclin B1 promoter activity increases, as expected, during the S/G2 period in all the cell lines. However, some promoter activity can be detected in G1 phase of the different cell line with BT-549 displaying the more altered pattern. Functional cyclin B1-cdk 1 protein complex was detected in G1 phase of BT-549 and T-47D cell lines. These results suggest that in a subset of transformed breast cancer cells altered cyclin B1 promoter activity may contribute to the misexpression of cyclin B protein. (C) 2002 Academic Press.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 43 条
[1]  
Alle KM, 1998, CLIN CANCER RES, V4, P847
[2]   CYCLIN D1 PROTEIN EXPRESSION AND FUNCTION IN HUMAN BREAST-CANCER [J].
BARTKOVA, J ;
LUKAS, J ;
MULLER, H ;
LUTZHOFT, D ;
STRAUSS, M ;
BARTEK, J .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :353-361
[3]   HUMAN P53 IS PHOSPHORYLATED BY P60-CDC2 AND CYCLIN-B-CDC2 [J].
BISCHOFF, JR ;
FRIEDMAN, PN ;
MARSHAK, DR ;
PRIVES, C ;
BEACH, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4766-4770
[4]  
BUCKLEY MF, 1993, ONCOGENE, V8, P2127
[5]  
COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782
[6]  
Faretta M, 1998, CYTOMETRY, V31, P53
[7]  
FAUST JB, 1992, CANCER RES, V52, P2460
[8]  
GILLETT C, 1994, CANCER RES, V54, P1812
[9]  
GONG JP, 1994, CANCER RES, V54, P4285
[10]  
Gorczyca W, 1997, MODERN PATHOL, V10, P457